Immune Design is a clinical-stage immunotherapy company employing next-generation in vivo approaches to enable the body's immune system to fight chronic diseases. The company's technologies are engineered to activate the immune system's natural ability to generate and/or expand antigen-specific cytotoxic T cells, while also enhancing other immune effectors, to fight cancer and other chronic diseases. CMB305 and G100, the two leading product candidates focused in cancer immunotherapy, are the first products from its two separate discovery platforms targeting dendritic cells in vivo, ZVexÂ® and GLAASÂ®. Both ZVex and GLAAS also have potential applications in infectious disease and allergy as demonstrated by ongoing pharmaceutical collaborations. Immune Design has offices in Seattle and South San Francisco. For more information, visit www.immunedesign.com.
The Principal Scientist/Director, Analytical Development is responsible for development of new methods or improvement of existing methods for characterization and release of our drug substances and drug products and for process characterization. Works closely with Research, Process Development and Quality Control to provide the appropriate level of support. A key focus for this position is identifying and implementing process analytical tools and technologies to improve process understandings and drives innovation, efficiency and productivity in the lab
PHYSICAL DEMANDS AND WORK ENVIRONMENT: